MENU
CGON
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
CG Oncology (CGON) Earnings Date & Reports
CG Oncology Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing its product candidate, cretostimogene grenadenorepvec, for patients with bladder cancer... Show more
A.I. Advisor
published Earnings
CGON is expected to report earnings to fall 4.44% to -86 cents per share on November 13
Q3'26
Est.
$-0.86
Q2'26
Missed
by $0.30
Q1'26
Missed
by $0.11
Q4'25
Missed
by $0.07
Q4'24
Missed
by $0.01
The last earnings report on August 06 showed earnings per share of -89 cents, missing the estimate of -60 cents. With 496.87K shares outstanding, the current market capitalization sits at 5.74B.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Interesting Articles
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Industry
N/A
Address
400 Spectrum Center Drive
Phone
+1 949 409-3700
Employees
142
Web
https://www.cgoncology.com